HAI-ROBOTICS
10.1.2022 09:02:10 CET | Business Wire | Press release
HAI ROBOTICS , a global leader in Autonomous Case-handling Robotic (ACR) system for warehouse logistics, announced that it has entered a strategic partnership with Greece's market leader in intralogistics, Voyatzoglou Systems , in a joint effort to offer more smart warehousing solutions to the supply chain in Greece and the Balkan area. The alliance marked the third the company has ever concluded in Europe as it keeps securing more footholds in the global intralogistics market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220110005066/en/
HAI ROBOTICS has gained extensive customer recognition with its warehousing automation solution HAIPICK ACR system running on more than 300 projects both in China and abroad. The system, independently developed as early as 2015, features flexible deployment and improved efficiency for warehouses that seek to maximize their storage spaces.
The HAIPICK robots, built with multiple sensors capable of integrated positioning, boasts a good control precision of ±3mm to allow intelligent picking, transport, auto-navigation, obstacle avoidance and auto-charging with high stability and high-accuracy. The HAIPICK robots can pick and place totes or cartons on storage shelves up to 10 meters high and are able to carry up to 8 loads to continuously feed goods-to-person picking stations. The newest invention of a fork-lifting robot is compatible with wider storage scenarios in which goods are not necessarily placed inside a box, such as tires and trays.
Kane Luo, Vice President of Sales from HAI ROBOTICS, said that the two parties are expected to complement each other by combining one side's project operation experience with localized service network of another. "We're impressed by the Voyatzoglou Systems' local service ability in the Balkan region. Our rich experience in automation solutions for a wide variety of sectors, from retail to 3PL and manufacturing plants, will be grafted onto local supply chain to improve efficiency and investment returns," he said, and added that all the HAIPICK ACR series have obtained the CE Mark, meeting European quality and safety standards.
“The partnership with HAI ROBOTICS allows us to extend our product portfolio by offering technologically state of the art and innovative solutions for material handling and goods to person. We believe that this collaboration will generate projects in automated warehouses, provide solid solutions to many of our customers seeking Autonomous Case-handling Robotic (ACR) systems and advance the market further," said Mrs. Annie Voyatzoglou, deputy CEO of Voyatzoglou Systems.
About Voyatzoglou
Voyatzoglou Systems is among the leading organizations in the Intralogistics and Shop Fitting sector in Greece, with a history of over 30 years. Cornerstone of their success are their strong operations, wide product portfolio with leading manufacturing companies and solid customer relationships. Voyatzoglou company caters to a wide range clientele, from large retail chains to 3PL companies and manufacturing plants. The last years Voyatzoglou Systems group of companies (both in Greece and Romania) have extended their activities from simple traditional warehouse shelving to automated and generally smart Logistics solutions. They have successfully delivered automated projects of high value to customers in Greece and the wide Balkan area.
Voyatzoglou Systems is a publicly traded company in the Greek Stock exchange, with a turnover of about 30 million euros, it employees more than 180 people and has its main premises in Athens Greece – with branch offices in Northern Greece and in Bucharest Romania through its subsidiary company Voyatzoglou Systems Romania SRL.
About HAI ROBOTICS
HAI ROBOTICS, a trailblazer of Autonomous Case-handling Robotic (ACR) system, is committed to providing efficient, intelligent, flexible, and customized warehouse automation solutions through robotics technology and AI algorithms. It aims to create value for each factory and logistics warehouse.
The HAIPICK ACR system, independently developed in 2015, is the world's first of its kind.
Founded in 2016 with headquarters in Shenzhen, China, HAI ROBOTICS has set up five subsidiaries in Hong Kong SAR, Japan, Singapore, the U.S. and the Netherlands, serving customers from more than 30 countries and regions. It now has over 1,300 staff, more than 50% of whom are engineers. The company has acquired more than 600 global patents for core intellectual properties involving positioning, robot control and warehouse management. In the latest C and D rounds of funding in 2021, the company raised over US$200 million in total.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220110005066/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom